🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 44 of 857 · Phase 3 first, then by program name

  1. Chestnut Bloomington Outpatient (CBOP)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 other completed

    1 trial

  2. Chickenpox Vaccines

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chickenpox Vaccines

    phase 3 mab completed

    1 trial

  3. ChimeriVax-JE, Japanese Encephalitis vaccine

    Sanofi Pasteur

    Encephalitis

    phase 3 mab completed

    1 trial

  4. Chirhostim

    The George Institute

    Pancreatic cancer, Intraductal papillary mucinous intraductal neoplasia

    phase 3 small molecule active

    1 trial

  5. Chlorhexidine

    United Therapeutics Europe Ltd

    Infant, Newborn, Diseases

    phase 3 small molecule active

    1 trial

  6. Cholecalciferol

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease

    phase 3 other completed

    1 trial

  7. Cholecalciferol

    United Therapeutics Europe Ltd

    Asthma

    phase 3 other completed

    1 trial

  8. Cholecalciferol (Vitamin D/Vigantol oil)

    United Therapeutics Europe Ltd

    Respiratory Tract Infections

    phase 3 other completed

    1 trial

  9. Cholic Acid

    Mirum Pharmaceuticals International B.V.

    Bile Acid Synthesis Defect

    phase 3 small molecule completed

    1 trial

  10. Cholic Acids

    Mirum Pharmaceuticals International B.V.

    Infantile Refsum's Disease

    phase 3 small molecule completed

    1 trial

  11. Cholic acid

    Mirum Pharmaceuticals International B.V.

    Inborn Errors of Bile Acid Synthesis

    phase 3 small molecule completed

    1 trial

  12. Choline Chloride for Injection

    Protara Therapeutics

    Choline Deficiency

    phase 3 small molecule active

    1 trial

  13. Chronocort®

    NEUROCRINE BIOSCIENCES INC

    Congenital Adrenal Hyperplasia

    phase 3 small molecule completed

    5 trials

  14. Cibinqo 100 mg film-coated tablets, Placebo for Abrocitinib 100mg tablet

    Pfizer Australia Pty Ltd

    Moderate to severe atopic dermatitis

    phase 3 small molecule active

    1 trial

  15. Cidofovir, Brincidofovir

    Lacuna Pharma Pty Ltd

    Adenovirus viremia

    phase 3 small molecule active

    1 trial

  16. Cilostazol-Elpen 100 mg Tabletten, Placebo de Cilostazol-Elpen 100mg, comprimé

    Pari Pharma GmbH

    Aneurysmal Subarachnoid Hemorrhage

    phase 3 small molecule active

    1 trial

  17. Cilta-cel

    Janssen Cilag International NV

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  18. Cimzia 200 mg solution for injection in pre-filled syringe, SODIUM CHLORIDE

    Pari Pharma GmbH

    Adult women with recurrent implantation failures (RIF)

    phase 3 small molecule active

    1 trial

  19. Cinryze®

    Takeda

    Acute Antibody-Mediated Rejection (AMR)

    phase 3 mab terminated

    1 trial

  20. Cipaglucosidase Alfa

    AMICUS THERAPEUTICS PTY LTD

    Pompe Disease (Late-onset)

    phase 3 mab completed

    1 trial

  21. Ciprofloxacin (BAYQ3939) dry powder for inhalation

    Bayer HealthCare AG

    Bronchiectasis

    phase 3 small molecule completed

    1 trial

  22. Cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 small molecule completed

    1 trial

  23. Cisplatin

    Children's Hospital of Fudan University

    Localized Osteosarcoma

    phase 3 small molecule completed

    1 trial

  24. Cisplatin

    BRIGHT MINDS BIOSCIENCES INC.

    Squamous Cell Carcinoma of Head and Neck

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources